Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
vaccines
Biotech
Moderna checks yea for influenza A, but nay on B in phase 3
Moderna checked off two influenza A strains in a phase 3 trial for an mRNA flu shot, but the vaccine struggled against two B strains in the same test.
Annalee Armstrong
Feb 17, 2023 5:30am
Despite emptying pipeline, AstraZeneca loyal to vaccine business
Feb 9, 2023 11:01am
Inovio hopes Ebola booster data can boost fortunes, too
Feb 2, 2023 9:50am
Early data from AC Immune Alzheimer's vaccine suggest response
Jan 26, 2023 11:13am
Novavax CEO retires after overseeing COVID shot launch
Jan 9, 2023 10:30am
CureVac's 'half-baked' COVID-flu data release questioned
Jan 6, 2023 10:45am
